title: Propranolol: a novel antihemangioma agent with multiple potential mechanisms of action.
authors.affiliation: Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China, Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China Research Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai, China Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China likai2727@163.com.
authors.forename: Yi
authors.initials: Y
authors.lastname: Ji
authors.forename: Siyuan
authors.initials: S
authors.lastname: Chen
authors.forename: Kai
authors.initials: K
authors.lastname: Li
authors.forename: Xianmin
authors.initials: X
authors.lastname: Xiao
authors.forename: Shan
authors.initials: S
authors.lastname: Zheng
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D042783:Endothelial Cells / Q000187:drug effects*; D006391:Hemangioma / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D000319:Adrenergic beta-Antagonists; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D042461:Vascular Endothelial Growth Factor A; D014665:Vasodilator Agents; D011433:Propranolol